Franz Peter Barthold
Corporate Officer/Principal bij JOTEC GmbH
Vermogen: 688 039 $ op 31-03-2024
Profiel
Franz Peter Barthold is currently the General Manager at JOTEC GmbH since 2020.
He previously worked as the Vice President-Research & Development at Artivion, Inc. Mr. Barthold completed his undergraduate degree at Hochschule Reutlingen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARTIVION, INC.
0.08% | 08-11-2022 | 32 516 ( 0.08% ) | 688 039 $ | 31-03-2024 |
Actieve functies van Franz Peter Barthold
| Bedrijven | Functie | Begin |
|---|---|---|
JOTEC GmbH
 JOTEC GmbH Medical SpecialtiesHealth Technology JOTEC GmbH manufactures and markets medical devices for aortic and peripheral vascular diseases. Its products include thoracic stent grafts, abdominal stent grafts, peripheral stent grafts, stents, e-Xtra design engineering, surgical portfolio and accessories. The company was founded on August 8, 2000 and is headquartered in Hechingen, Germany. | Corporate Officer/Principal | 01-07-2020 |
Eerdere bekende functies van Franz Peter Barthold
| Bedrijven | Functie | Einde |
|---|---|---|
| ARTIVION, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Franz Peter Barthold
| Hochschule Reutlingen | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARTIVION, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
JOTEC GmbH
JOTEC GmbH Medical SpecialtiesHealth Technology JOTEC GmbH manufactures and markets medical devices for aortic and peripheral vascular diseases. Its products include thoracic stent grafts, abdominal stent grafts, peripheral stent grafts, stents, e-Xtra design engineering, surgical portfolio and accessories. The company was founded on August 8, 2000 and is headquartered in Hechingen, Germany. | Health Technology |
